The purpose of this study is to determine the safety and efficacy of bilateral intramuscular
injections of VM202 versus placebo in the treatment of painful diabetic neuropathy.
A total of 477 subjects will be randomized in a 2:1 ratio to one of two treatment groups:
Treatment - VM202 - 318 subjects Control - Placebo (VM202 vehicle) - 159 subjects
Randomization will be stratified by current use of gabapentin and/or pregabalin.